Beckman Announces Sale of Minority Interest in Agencourt Personal Genomics
News May 31, 2006
This follows from an agreement between APG and Applied Biosystems Group, an Applera Corporation business whereby Applied Biosystems will acquire APG subject to regulatory and other customary closing conditions.
Beckman Coulter acquired shares of APG in conjunction with its acquisition of Agencourt Bioscience in May 2005.
Beckman Coulter expects to receive about $50 million in cash from the transaction which is anticipated to close in the third quarter of 2006.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.